Topiramate
Product Images NDC 70934-733

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 733 60 Master Bottle Label Approval Rev A 10 20)

This is the product label information for Topiramate tablets, USP with 50mg strength and 60 tablets per bottle that carries the National Drug Code (NDC) 70934-733-60. No further information is available due to the lack of clear text obtained by conversion.*

FDA Label Image

Figure1.jpg (Figure1)

The text shows a chart indicating cumulative rates for Time to First Seizure. The x-axis indicates the time in days and the y-axis represents the cumulative rate. Two data sets are presented - Topiramate 50 mg/day (N=234) and Topiramate 400 mg/day (N=238), represented by different symbols.*

FDA Label Image

Figure2.jpg (Figure2)

The text describes a table showing the change in average monthly migraine period rate from baseline to double-blind phase in four different treatments - placebo, topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The numbers in parentheses indicate the number of participants in each treatment group. The table is labeled with the names of Study 10 and Study 11, and includes two asterisks indicating statistically significant differences between treatments. No other information is available.*

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.